Canine vaccine for protection against ehrlichiosis

Details Canine vaccine for protection against ehrlichiosis Canine vaccine for protection against ehrlichiosis

2006-04-20

2009-12-22

Mondesi, Robert B (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S184100, C424S278100

Reexamination Certificate

active

07635481

ABSTRACT:
The present invention provides a safe and effective vaccine composition which comprises: an effective immunizing amount of an inactivatedEhrlichia canisbacterin; a pharmacologically acceptable carrier; and an immunogenically stimulating amount of an adjuvant system consisting essentially of an antibody response inducing agent and a cell-mediated immunity response inducing agent.The present invention also provides a method for the prevention or amelioration of canine ehrlichiosis in dogs.

REFERENCES:
patent: 5192679 (1993-03-01), Dawson et al.
patent: 6043085 (2000-03-01), Yu et al.
patent: 6432649 (2002-08-01), Stich et al.
patent: 6458942 (2002-10-01), Walker et al.
patent: 2003/0129161 (2003-07-01), Chu
patent: WO 98/42743 (1998-10-01), None
Boslego, J. et al (Gonorrhea Vaccines, Chapter 17, 211-223).
Ellis, R (New Technologies for Making Vaccines, text book, 1998, 568-575).
Maender et al (Treatment and prevention of rickettsial and ehrlichial infections, Dermatological Therapy, 2004; 17: 499-504).
Nash, H., Ehrlichiosis in Dogs, http://www.peteducation.com, p. 1-3).
Rikihisam, Y., Human Ehrichiosis, Ohio State University, http://riki-1b1.vet.ohio-state.edu/ehrlichia/background/ehrlichiosis.php, pp. 1-2.
Keysary et al., “The first isolation, in vitro propagation, and genetic characterization ofEhrlichia canisin Israel,” Veterinary Parasitology, vol. 62, 1996, pp. 331-340.
McBride et al., “Glycosylation of Homologous Immunodominant Proteins ofEhrlichia chaffeensisandEhrlichia canis,” Infection and Immunity, vol. 68, No. 1, Jan. 2000, pp. 13-18.
Bowie et al., “Potential Value of Major Antigenic Protein 2 for Serological Diagnosis of Heartwater and Related Ehrlichial Infections,” Clinical and Diagnostic Laboratory Immunology, vol. 6, No. 2, Mar. 1999, pp. 209-215.
Unver et al., “Molecular and Antigenic Comparison ofEhrlichia canisIsolates from Dogs, Ticks, and a Human in Venezuela,” Journal of Clinical Microbiology, vol. 39, No. 8, Aug. 2001, pp. 2788-2793.
Mathew et al., “Attempted transmission ofEhrlichia canisbyRhipicephalus sanguineusafter passage in cell culture,” American Journal of Veterinary Research, vol. 57, No. 11, Nov. 1996, pp. 1594-1598.
Dawson et al., “Serologic Diagnosis of Human Ehrlichiosis Using TwoEhrlichia canisIsolates,” Journal of Infectious Diseases, vol. 163, 1991, pp. 564-567.
Keysary et al., “Cultivation ofEhrlichia canisin a continuous BALB/C mouse macrophage cell culture line,” Journal of Veterinary Diagnostic Investigation, vol. 13, 2001, pp. 521-523.
Unver et al., “Analysis of 16S rRNA Gene Sequences ofEhrlichia canis, Anaplasma platys,andWolbachiaSpecies from Canine Blood in Japan,” Annals of New York Academy of Sciences, vol. 990, 2003, pp. 692-698.
Dancey et al., “Effect of Liposomal Model Membrane Composition on Immunogenicity,” The Journal of Immunology, vol. 120, No. 4, Apr. 1978, pp. 1109-1113.
Allison et al., “Liposomes as immunological adjuvants,” Nature, vol. 252, Nov. 15, 1974, pp. 252-254.
McBride et al., “Kinetics of Antibody Response toEhrlichia canisImmunoreactive Proteins,” Infection and Immunity, vol. 71, No. 5, May 2003, pp. 2516-2524.
Mwangi et al., “Immunization of Cattle by Infection withCowdria ruminantiumElicits T Lymphocytes That Recognize Autologous, Infected Endothelial Cells and Monocytes,” Infection and Immunity, vol. 66, No. 5, May 1998, pp. 1855-1860.
Rikihisa, Y., “Protection Against Murine Potomac Horse Fever by an InactivatedEhrlichia risticiiVaccine,” Veterinary Microbiology, vol. 27, 1991, pp. 339-350.
Hemelt et al., “Serial propagation ofEhrlichia canisin primary canine peripheral blood monocyte cultures,” The Cornell Veterinarian, vol. 70, No. 1, Jan. 1980, pp. 36-42.
Kakoma et al., “Autologous lymphocyte-mediated cytotoxicity against monocytes in canine ehrlichiosis,” American Journal of Veterinary Research, vol. 38, No. 10, Oct. 1977, pp. 1557-1559.
Nyindo et al., “Cell-mediated and humoral immune responses of German Shepherd Dogs and Beagles to experimental infection withEhrlichia canis.,” American Journal of Veterinary Research, vol. 41, No. 2, 1980, pp. 250-254.
Esteves et al., “Analysis ofEhrlichia ruminantium-specific T1/T2 responses during vaccination with a protective killed vaccine and challenge of goats,” Parasite Immunology, vol. 26, No. 2, Feb. 2004, pp. 95-103.
Boslego et al., Chapter 17, Gonorrhea Vaccines, 1991, pp. 211-223, in Vaccines and Immunotherapy, Pergamon press, Edited by Stanley J. Cryz, Jr.
Ellis, R., Chapter 29, New Technologies for Making Vaccines, 1998, pp. 568-575, in Vaccines, WB Sunders Company.
Maender et al., “Treatment and prevention of rickettsial and ehrlichial infections,” Dermatological Therapy, vol. 17, 2004, pp. 499-504.
Nash, H., “Ehrlichiosis [in Dogs],” Veterinary Services Department, Drs. Foster & Smith, Inc., http://www.peteducation.com, pp. 1-3, Oct. 13, 2005.
Rikihisa, Y. (Primary Investigator), “Human Ehrlichiosis,” Ehrlichial Research Laboratory, Department of Veterinary Biosciences, Ohio State University, http://riki-lb1.vet.ohio-state.edu/ehrlichia/background/ehrlichiaspp.php, pp. 1-2, Oct. 13, 2005.

Affiliated with

Also associated with

Rating

Canine vaccine for protection against ehrlichiosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Canine vaccine for protection against ehrlichiosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine vaccine for protection against ehrlichiosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4053358